Submit Release
News Search

There were 459 press releases posted in the last 24 hours and 357,391 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Nivalis Therapeutics Announces Completion of Enrollment in Second Phase 2 Study of Cavosonstat for Treatment of Cystic Fibrosis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.

We use cookies to enhance your experience. Learn more